Study guide

1.2 Specialized Federal Privacy Laws: 42 CFR Part 2, GINA, FERPA, and Cures Act Information Blocking

AHIMA Certified in Healthcare Privacy and Security CHPS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Healthcare Privacy & Security Legal Framework

1.1 HIPAA Statutory Architecture, HITECH Act, and Enforcement Evolution 1.2 Specialized Federal Privacy Laws: 42 CFR Part 2, GINA, FERPA, and Cures Act Information Blocking 1.3 State Law Preemption Analysis, Stringency Standards, and Multi-State Compliance

2 Chapter 2: Governance, Officer Responsibilities & Compliance Documentation

2.1 Privacy Officer vs. Security Officer: Roles, Governance, and Dual Accountability 2.2 Healthcare Accreditation Standards: Joint Commission, NCQA, and CARF Privacy Requirements 2.3 Documentation, Production, and Record Retention Mandates (State vs. Federal 6-Year Rule)

3 Chapter 3: Notice of Privacy Practices & Patient Rights

3.1 Notice of Privacy Practices (NPP): Content Requirements, Distribution, and Acknowledgment 3.2 Individual Right of Access: Timelines, Digital Formats, and Fee Limitations 3.3 Patient Rights: Amendments, Accounting of Disclosures, and Restriction Requests 3.4 Operational Workflows for Managing Patient Rights and Dispute Resolution

4 Chapter 4: Designated Record Sets, Special Protections & Release Protocols

4.1 Defining the HIPAA Designated Record Set (DRS) Across Clinical and Billing Systems 4.2 Special Privacy Protections: Mental Health, Psychotherapy Notes, SUD Records, and Reproductive Healthcare 4.3 Legal Demands for PHI: Subpoenas, Court Orders, Warrants, and Law Enforcement Inquiries 4.4 Verification Protocols for Requestor Identity, Legal Authority, and Release of Information (ROI)

5 Chapter 5: Minimum Necessary, De-Identification & Research Disclosures

5.1 Minimum Necessary Standard: Protocols, Role-Based Access, and Mandatory Exceptions 5.2 De-Identification Methodologies: Safe Harbor 18 Identifiers vs. Formal Expert Determination 5.3 PHI in Clinical Research: IRB Waivers, Preparatory to Research, Decedents, and Limited Data Sets (DUA)

6 Chapter 6: Business Associates, Contracts & Workforce Training

6.1 Business Associate Agreements (BAA): Mandatory Provisions, Subcontractor Flow-Down, and Liability 6.2 Vendor Risk Management and Service Level Agreements (SLAs) for Health Data 6.3 Workforce Privacy and Security Training: Curriculum Design, Delivery, and Retraining Triggers 6.4 Policy Management Lifecycle: Policy Formulation, Regular Review, and Organizational Communication

7 Chapter 7: Information Security Plan & Asset Risk Analysis

7.1 Developing and Maintaining an Organizational Information Security Plan (ISP) 7.2 Hardware, Software, and Sensitive Data Asset Inventories and Criticality Categorization 7.3 HIPAA Security Rule Risk Analysis: Threat Identification, Vulnerabilities, and NIST SP 800-30 Alignment

8 Chapter 8: Access Control Systems, Authentication & Emergency Operations

8.1 Access Authorization and Privilege Management: Role-Based (RBAC) and Attribute-Based Controls 8.2 Authentication Architectures: Multi-Factor Authentication (MFA), Passwords, and Identity Proofing 8.3 Emergency Access Protocols: "Break-Glass" Workflows, Documentation, and Post-Event Review 8.4 Information System Activity Review: Audit Logs, Access Tracking, and Anomaly Monitoring

9 Chapter 9: Technical Safeguards, Cryptography & Network Security

9.1 Data Encryption Standards: In Transit (TLS) vs. At Rest (AES-256) and FIPS Validation 9.2 Network Architecture Security: Firewalls, DMZ, Segmentation, and Wireless Protections 9.3 Secure External Data Transmission: Direct Messaging, SFTP, APIs, and FHIR Security 9.4 Event Triggering, Intrusion Detection/Prevention (IDS/IPS), and Security Information Event Management (SIEM)

10 Chapter 10: Physical Safeguards, Media Controls & Facility Security

10.1 Facility Access Controls: Visitor Policies, Physical Access Tracking, and Building Security 10.2 Workstation Use and Security: Screen Privacy, Physical Placement, and Clean Desk Standards 10.3 Media Control Lifecycle: Receipt, Movement, Re-Use, and Sanitization/Destruction (NIST SP 800-88)

11 Chapter 11: Business Continuity, Disaster Recovery & Contingency Planning

11.1 Contingency Planning Frameworks: Business Impact Analysis (BIA) and Emergency Mode Operations 11.2 Data Backup Plans, Redundancy Architectures, and Off-Site Storage Strategies 11.3 Disaster Recovery and Testing: RTO, RPO, Downtime Procedures, and Restoration Validation

12 Chapter 12: Incident Response, Investigation Protocols & Mitigation

12.1 Security and Privacy Incident Intake, Triage, and Response Team (CSIRT/PIRT) Structure 12.2 Investigating Privacy and Security Complaints: Evidence Gathering and Root-Cause Analysis 12.3 Immediate Containment and Harm Mitigation Strategies for Breaches and Exposures 12.4 Disciplinary Guidelines and Sanctions Enforcement for Workforce Non-Compliance

13 Chapter 13: Federal Breach Notification Rule & Risk Assessment

13.1 Federal Breach Notification Rule Definition, Exceptions, and Safe Harbors 13.2 The Four-Factor Breach Risk Assessment Methodology and Documentation 13.3 Individual Notification Requirements: Content, Timelines (60-Day Clock), and Substitute Notice 13.4 Entity Notification Mandates: HHS OCR Reporting (<500 vs. ≥500) and Media Notifications

14 Chapter 14: Compliance Auditing, External Investigations & Enforcement Tiers

14.1 Ongoing Compliance Auditing, Risk Metrics, and Executive/Board Governance Reporting 14.2 Managing External Investigations: Responding to OCR Inquiries, Subpoenas, and State AGs 14.3 Enforcement Penalties: HIPAA Civil Monetary Penalty Tiers, Resolution Agreements, and Criminal Sanctions

1.2 Specialized Federal Privacy Laws: 42 CFR Part 2, GINA, FERPA, and Cures Act Information Blocking

Key Takeaways Explain This Topic AI

42 CFR Part 2 applies exclusively to federally assisted specialized Substance Use Disorder (SUD) programs, enforcing strict consent rules and a mandatory written prohibition on re-disclosure notice (42 CFR § 2.32).

The 2024 SAMHSA/HHS Part 2 Final Rule aligned SUD privacy with HIPAA by permitting single broad consent for all future Treatment, Payment, and Operations (TPO), applying the HIPAA Breach Notification Rule, and aligning civil penalty structures.

Under GINA (Public Law 110-233) and 45 CFR § 164.502(a)(5)(i), genetic information is classified as PHI, and health plans are strictly prohibited from utilizing genetic data (including family medical history) for underwriting purposes.

Student health and immunization records maintained by educational institutions subject to FERPA (34 CFR Part 99) are classified as 'education records' or 'treatment records' and are expressly excluded from the definition of PHI under HIPAA (45 CFR § 160.103).

The 21st Century Cures Act Information Blocking Rule (45 CFR Part 171) prohibits healthcare providers, health IT developers, and health information exchanges from interfering with the access, exchange, or use of Electronic Health Information (EHI), subject to 10 narrow regulatory exceptions.

Last updated: October 2026

Specialized Federal Privacy Laws: 42 CFR Part 2, GINA, FERPA, and Cures Act Information Blocking

While HIPAA establishes the general federal baseline for health information privacy and data security, it does not operate in a vacuum. A complex matrix of specialized federal statutes imposes heightened protections on specific categories of sensitive health data—including substance use disorder treatment, human genomics, and education-linked clinical records. Furthermore, modern federal policy actively penalizes the unreasonable withholding of electronic health data under interoperability mandates.

Health privacy and security officers must master these specialized statutes to prevent severe regulatory conflicts, discriminatory data use, and significant administrative penalties.

42 CFR Part 2: Confidentiality of Substance Use Disorder (SUD) Patient Records

Codified under the statutory authority of Section 543 of the Public Health Service Act (42 U.S.C. § 290dd-2), 42 CFR Part 2 safeguards the privacy of individuals seeking diagnosis, treatment, or referral for Substance Use Disorder (SUD). Enacted during the 1970s amid intense social stigma and fear of criminal prosecution, Part 2 provides protections that are substantially more restrictive than general HIPAA standards.

Applicability and Scope: What Qualifies as a Part 2 Program?

Part 2 does not apply to every healthcare entity that treats a patient with an addiction. It applies exclusively to federally assisted programs that hold themselves out as providing SUD services:

Federally Assisted: Broadly construed to include any entity that receives federal funds (Medicare/Medicaid reimbursement, federal grants), is authorized to conduct business by the federal government (DEA registration to dispense controlled substances like buprenorphine or methadone), or operates with tax-exempt non-profit status.

Part 2 'Program': An individual or entity (other than a general medical facility) that holds itself out as providing, and provides, SUD diagnosis, treatment, or referral for treatment; OR an identified unit within a general medical facility that holds itself out as providing SUD services; OR medical personnel or other staff in a general medical facility whose primary function is the provision of SUD services.

Critical Distinction: An emergency department physician in a general acute care hospital who stabilizes an acute opioid overdose is not a Part 2 program. However, a specialized inpatient addiction recovery unit operated within that same hospital is a Part 2 program.

SUD Patient Consent Requirements

Historically, Part 2 prohibited any disclosure of SUD records without specific patient consent, even for routine medical treatment, except in bona fide medical emergencies (§ 2.51) or pursuant to specialized court orders (§§ 2.61–2.67). Disclosures made with consent were required to include the mandatory statutory Notice to Accompany Disclosure (42 CFR § 2.32):

"This record which has been disclosed to you is protected by federal confidentiality rules (42 CFR Part 2). The federal rules prohibit you from making any further disclosure of this information unless further disclosure is expressly permitted by the written consent of the person to whom it pertains..."

The CARES Act of 2020 and the 2024 Final Rule Modernization

Section 3221 of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 directed HHS and SAMHSA to align 42 CFR Part 2 with HIPAA. The 2024 SAMHSA/HHS Final Rule modernized Part 2 while retaining core anti-discrimination and criminal justice protections:

Single Broad Consent for Future TPO: Patients may now execute a single, universal consent permitting the Part 2 program to disclose their SUD records for all future Treatment, Payment, and Health Care Operations (TPO) in alignment with HIPAA. Once disclosed to a HIPAA covered entity or business associate, those records may be re-disclosed in accordance with the HIPAA Privacy Rule (except in legal proceedings against the patient).

Alignment of Breach Notification: The HIPAA Breach Notification Rule (45 CFR Part 164 Subpart D) now formally applies to unauthorized breaches of Part 2 records.

Enforcement Alignment: Historic criminal misdemeanor fines were replaced with direct Civil Monetary Penalty tiers under HITECH / HIPAA (45 CFR Part 160) enforced by HHS OCR.

Patient Rights: Granted Part 2 patients the formal right to request an accounting of disclosures and the right to request restrictions on disclosures for TPO.

Shielding Records in Legal Proceedings: Absolute prohibition against using Part 2 records, testimony, or evidence in criminal, civil, administrative, or legislative proceedings against the patient without an explicit court order based on good cause and a showing that other means of obtaining the information are unavailable.

Notice of Privacy Practices: A conforming amendment to 45 CFR § 164.520 requires covered entities that create, receive, or maintain Part 2 records to revise and redistribute their NPP to describe Part 2 protections.

Effective Date vs. Compliance Date: The 2024 Part 2 Final Rule was published on February 16, 2024 and took effect on April 16, 2024 , but HHS granted a two-year transition period: full compliance, including the revised Notice of Privacy Practices, was required by February 16, 2026 . Expect the exam to test this distinction, since the effective date and the compliance date are two years apart.

Genetic Information Nondiscrimination Act of 2008 (GINA)

Enacted as Public Law 110-233, the Genetic Information Nondiscrimination Act (GINA) protects individuals from genetic discrimination in health insurance and employment. GINA addresses public anxiety that genetic testing for hereditary diseases (e.g., BRCA1/BRCA2 breast cancer mutations or Huntington's disease) could lead to insurance cancellation or job loss.

Statutory Structure of GINA

Title I (Health Insurance Protections): Prohibits group health plans and individual health insurance issuers from adjusting premiums, modifying contribution amounts, conditioning eligibility, or imposing pre-existing condition exclusions based on genetic information. Plans are strictly prohibited from requesting, requiring, or purchasing genetic information for underwriting purposes.

Title II (Employment Protections): Prohibits employers, employment agencies, and labor organizations from using genetic information in hiring, discharge, compensation, terms, or privileges of employment. Employers cannot request, require, or purchase genetic data, with narrow exceptions (e.g., voluntary wellness programs with explicit written consent, or FMLA documentation).

Definition of Genetic Information

Under GINA § 201 and the HIPAA Privacy Rule, genetic information includes:

An individual's genetic tests (e.g., DNA, RNA, chromosomal analyses).

The genetic tests of family members of the individual (up to fourth-degree relatives).

The manifestation of a disease or disorder in family members of the individual ( family medical history ).

Requests for, or receipt of, genetic services (genetic counseling, education, or clinical research testing).

HIPAA Privacy Rule Integration (45 CFR § 164.502(a)(5)(i))

Pursuant to GINA mandates, the 2013 HIPAA Omnibus Rule explicitly amended the Privacy Rule to classify genetic information as PHI and codified a categorical underwriting ban:

A health plan (other than an issuer of long-term care policies) shall not use or disclose protected health information that is genetic information for underwriting purposes. (45 CFR § 164.502(a)(5)(i))

Underwriting purposes include determining eligibility, computing premiums, applying pre-existing condition limits, and creating or adjusting policy terms.

Critical Candidate Trap: GINA's underwriting prohibition applies exclusively to health insurance . GINA does not apply to life insurance, disability insurance, or long-term care insurance policies unless prohibited by specific state statutes.

FERPA vs. HIPAA: Student Health Records and Educational Institutions

The boundary between the Family Educational Rights and Privacy Act of 1974 (FERPA, 20 U.S.C. § 1232g; 34 CFR Part 99) and the HIPAA Privacy Rule is one of the most heavily tested jurisdictional concepts on the CHPS exam.

The Statutory Exclusion under HIPAA

Under the statutory definitions of the HIPAA Privacy Rule, Congress explicitly excluded educational records from the definition of PHI:

Protected health information excludes individually identifiable health information in: (i) Education records covered by the Family Educational Rights and Privacy Act, as amended, 20 U.S.C. 1232g; (ii) Records described at 20 U.S.C. 1232g(a)(4)(B)(iv) [student treatment records]... (45 CFR § 160.103)

Because of this express carve-out, an educational institution subject to FERPA cannot simultaneously hold HIPAA PHI for enrolled students . Educational Healthcare Jurisdiction Flowchart:

  • Clinical Record Created at Educational Facility
  • │
  • ├──► Primary/Secondary School (K-12) Public / Federally Funded
  • │ └── Governed 100% by FERPA as Education Records (Parents hold access rights)
  • │
  • └──► Postsecondary Institution (College / University Health Clinic)
  • │
  • ├── Patient is Enrolled Student
  • │ └── Governed by FERPA as Student Treatment Records (Excluded from HIPAA)
  • │
  • └── Patient is Non-Student (Faculty, Staff, or Community Member)
  • └── Governed by HIPAA Privacy Rule as PHI (Hybrid Entity Status Required)
  • Operational Distinctions: K-12 vs. Postsecondary Institutions

K-12 Public Schools: Student health records (immunization charts, nurse visit logs, IEP medical evaluations) maintained by a school receiving federal funding from the Department of Education are education records under FERPA . Parents have the right to inspect and review these records under 34 CFR § 99.10. HIPAA does not apply, even if the school bills Medicaid electronically for special education services.

University Health Clinics (Hybrid Entities): Postsecondary student medical charts maintained by university physicians are FERPA Treatment Records . They are maintained solely for medical care and can only be disclosed to treating professionals or with the student's written consent. However, if the university clinic also opens its doors to treat non-student faculty, staff, or local community members , records for those individuals are HIPAA PHI . The university must designate itself as a Hybrid Entity under 45 CFR § 164.105, strictly firewalling FERPA student treatment records from HIPAA PHI databases.

21st Century Cures Act & ONC Information Blocking Rule

Enacted in December 2016 (Public Law 114-255), the 21st Century Cures Act introduced landmark statutory mandates to eliminate electronic data siloing. While HIPAA established rules regarding when health data may be shared or must be protected, the Office of the National Coordinator for Health Information Technology (ONC) Information Blocking Rule (45 CFR Part 171) establishes mandates regarding when data must not be withheld .

Definition of Information Blocking (45 CFR § 171.103)

Information blocking is defined as a business, operational, or technical practice that is likely to interfere with, prevent, or materially discourage access, exchange, or use of Electronic Health Information (EHI) .

Regulated Actors and Subjective Intent Standards

The rule applies to three distinct categories of 'Actors', each governed by a specific statutory knowledge standard:

Healthcare Providers: Any hospital, skilled nursing facility, physician practice, or clinical laboratory. Knowledge Standard: The provider knows that the practice is unreasonable and is likely to interfere with access, exchange, or use of EHI.

Health IT Developers of Certified Health IT: Vendors of certified electronic health record technology (CEHRT). Knowledge Standard: The developer knows, or should know , that the practice is likely to interfere with access, exchange, or use of EHI.

Health Information Networks (HINs) / Health Information Exchanges (HIEs): Entities that orchestrate multi-provider data routing. Knowledge Standard: The HIN/HIE knows, or should know , that the practice is likely to interfere with access, exchange, or use of EHI.

Scope of Electronic Health Information (EHI)

EHI encompasses all individually identifiable electronic health data to the extent it is transmitted or maintained in electronic media and would be classified as part of a Designated Record Set (DRS) under HIPAA (45 CFR § 164.501). It includes clinical notes, diagnostic imaging, lab results, billing records, and pathology reports, structured around the United States Core Data for Interoperability (USCDI) .

The 10 Information Blocking Exceptions (45 CFR Part 171)

Failing to provide electronic access is not a violation if the actor satisfies all operational criteria of one of the 10 regulatory exceptions , grouped as follows:

Exception Category Exception Name 45 CFR Citation Regulatory Summary & Operational Criteria

Exceptions that Involve NOT Fulfilling Requests Preventing Harm § 171.201 The actor holds a reasonable belief that withholding EHI substantially reduces a risk of physical harm to a patient or other person, determined by an individualized clinical assessment.

Privacy § 171.202 Withholding EHI is required by federal (HIPAA, 42 CFR Part 2) or state privacy law, or specific statutory preconditions (e.g., patient consent) have not been satisfied.

Security § 171.203 Practice is tailored to protect the confidentiality, integrity, or availability of EHI against specific cybersecurity threats, consistent with organizational security policies.

Infeasibility § 171.204 Actor cannot fulfill the request due to uncontrollable events (war, disaster, cyberattack), technical inability to segment data, or documented infeasibility under the circumstances.

Health IT Performance § 171.205 Systems are temporarily unavailable due to planned maintenance, software upgrades, or performance degradation remediation.

Protecting Care Access § 171.206 Actor limits sharing in good faith to reduce potential legal exposure tied to lawful reproductive health care, when the exception's conditions are met.

Exceptions that Involve Procedures for Fulfilling Requests Manner (formerly Content and Manner) § 171.301 Actor fulfills request using alternative standard technical formats (e.g., FHIR APIs or USCDI formats) when unable to provide the exact technical manner requested.

Fees § 171.302 Actor charges objective, cost-based fees reasonably related to providing access, strictly excluding fees for electronic access via patient portals or standard APIs.

Licensing § 171.303 Actor licenses interoperability software elements on fair, reasonable, and non-discriminatory (FRAND) terms.

Exception Involving TEFCA Participation TEFCA Manner § 171.403 When both parties take part in TEFCA, the actor may fulfill certain requests only via TEFCA, subject to the exception's conditions.

Enforcement and Penalties

Developers and HIEs: Investigated by the HHS Office of Inspector General (OIG); subject to Civil Monetary Penalties of up to $1,000,000 per violation .

Healthcare Providers: Under the CMS/OIG final rule, non-compliant providers face appropriate disincentives across Medicare programs, including zero scores in the MIPS Promoting Interoperability performance category and exclusion from the Medicare Shared Savings Program (MSSP) for at least one year.

Multi-Law Comparative Synthesis

Dimension 42 CFR Part 2 GINA (Title I / II) FERPA (34 CFR Part 99) HIPAA Privacy Rule Cures Act Info Blocking

Primary Scope Specialized SUD treatment records Genetic tests & family medical history Student education & treatment records Individually identifiable PHI Electronic Health Information (EHI)

Primary Regulator SAMHSA / HHS OCR EEOC / HHS OCR Department of Education (FPCO) HHS Office for Civil Rights ONC / HHS OIG / CMS

TPO Sharing Without Consent Historically No; 2024 Rule permits single broad TPO consent Prohibited for health plan underwriting Prohibited without parental/student consent Permitted without authorization (§ 164.506) Mandated; withholding constitutes blocking

Individual Rights Access, accounting, restriction (2024 Rule) Protection against underwriting / job bias Parental/student inspection & amendment Access, amendment, accounting, restrictions Immediate electronic access via portal/API

CHPS Exam Tips and Common Traps

Tip

Exam Tip: The 'Preventing Harm' Standard Requires Physical Harm When an exam question involves withholding records under the Information Blocking 'Preventing Harm' exception (45 CFR § 171.201), remember that the risk must be physical harm to the patient or another individual. A physician's desire to withhold a bad prognosis (e.g., terminal cancer staging) simply to prevent emotional distress or anxiety does not qualify for the Preventing Harm exception unless the clinician documents a substantial risk of self-harm or physical violence.

Warning

Candidate Trap: General Hospitals Receiving Part 2 Records When a general acute care hospital receives Part 2 SUD records pursuant to patient consent, those records do not suddenly lose their statutory protection. While the 2024 Final Rule permits re-disclosure for TPO if the patient executed a broad consent, the receiving hospital cannot use those records in any civil or criminal proceeding against the patient without a specialized Part 2 court order under Subpart E.

Caution

Candidate Trap: Assuming GINA Covers Life and Disability Policies A standard exam question presents an individual undergoing predictive genetic screening who is subsequently denied a $1,000,000 life insurance policy or long-term care policy based on BRCA2 positivity. Candidates incorrectly flag this as an illegal GINA violation. GINA Title I covers health insurance exclusively ; life, disability, and long-term care underwriters are legally permitted to review and underwrite based on genetic data unless restricted by state insurance law.

Loading diagram... Specialized Federal Health Data Privacy and Interoperability Framework